Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 2
1961 1
1962 2
1963 1
1964 1
1965 1
1966 1
1967 1
1968 3
1969 4
1970 2
1971 4
1972 4
1973 1
1974 2
1975 6
1976 5
1977 2
1978 4
1979 6
1980 8
1981 8
1982 11
1983 8
1984 8
1985 4
1986 9
1987 7
1988 6
1989 8
1990 17
1991 18
1992 21
1993 17
1994 19
1995 10
1996 8
1997 12
1998 14
1999 11
2000 22
2001 22
2002 21
2003 27
2004 14
2005 24
2006 24
2007 23
2008 36
2009 39
2010 38
2011 33
2012 47
2013 48
2014 48
2015 40
2016 59
2017 60
2018 59
2019 49
2020 63
2021 33
Text availability
Article attribute
Article type
Publication date

Search Results

1,006 results
Results by year
Filters applied: . Clear all
Page 1
Glucocorticoids promote breast cancer metastasis.
Obradović MMS, Hamelin B, Manevski N, Couto JP, Sethi A, Coissieux MM, Münst S, Okamoto R, Kohler H, Schmidt A, Bentires-Alj M. Obradović MMS, et al. Among authors: okamoto r. Nature. 2019 Mar;567(7749):540-544. doi: 10.1038/s41586-019-1019-4. Epub 2019 Mar 13. Nature. 2019. PMID: 30867597
BNP as a Major Player in the Heart-Kidney Connection.
Okamoto R, Ali Y, Hashizume R, Suzuki N, Ito M. Okamoto R, et al. Int J Mol Sci. 2019 Jul 22;20(14):3581. doi: 10.3390/ijms20143581. Int J Mol Sci. 2019. PMID: 31336656 Free PMC article. Review.
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.
Robak T, Huang H, Jin J, Zhu J, Liu T, Samoilova O, Pylypenko H, Verhoef G, Siritanaratkul N, Osmanov E, Alexeeva J, Pereira J, Drach J, Mayer J, Hong X, Okamoto R, Pei L, Rooney B, van de Velde H, Cavalli F; LYM-3002 Investigators. Robak T, et al. Among authors: okamoto r. N Engl J Med. 2015 Mar 5;372(10):944-53. doi: 10.1056/NEJMoa1412096. N Engl J Med. 2015. PMID: 25738670 Free article. Clinical Trial.
Organoid-based regenerative medicine for inflammatory bowel disease.
Okamoto R, Shimizu H, Suzuki K, Kawamoto A, Takahashi J, Kawai M, Nagata S, Hiraguri Y, Takeoka S, Sugihara HY, Yui S, Watanabe M. Okamoto R, et al. Regen Ther. 2020 Jan 13;13:1-6. doi: 10.1016/j.reth.2019.11.004. eCollection 2020 Mar. Regen Ther. 2020. PMID: 31970266 Free PMC article. Review.
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study.
Robak T, Jin J, Pylypenko H, Verhoef G, Siritanaratkul N, Drach J, Raderer M, Mayer J, Pereira J, Tumyan G, Okamoto R, Nakahara S, Hu P, Appiani C, Nemat S, Cavalli F; LYM-3002 investigators. Robak T, et al. Among authors: okamoto r. Lancet Oncol. 2018 Nov;19(11):1449-1458. doi: 10.1016/S1470-2045(18)30685-5. Epub 2018 Oct 19. Lancet Oncol. 2018. PMID: 30348538 Clinical Trial.
TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy.
Matsuzawa Y, Oshima S, Takahara M, Maeyashiki C, Nemoto Y, Kobayashi M, Nibe Y, Nozaki K, Nagaishi T, Okamoto R, Tsuchiya K, Nakamura T, Ma A, Watanabe M. Matsuzawa Y, et al. Among authors: okamoto r. Autophagy. 2015;11(7):1052-62. doi: 10.1080/15548627.2015.1055439. Autophagy. 2015. PMID: 26043155 Free PMC article.
Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression.
Lama L, Adura C, Xie W, Tomita D, Kamei T, Kuryavyi V, Gogakos T, Steinberg JI, Miller M, Ramos-Espiritu L, Asano Y, Hashizume S, Aida J, Imaeda T, Okamoto R, Jennings AJ, Michino M, Kuroita T, Stamford A, Gao P, Meinke P, Glickman JF, Patel DJ, Tuschl T. Lama L, et al. Among authors: okamoto r. Nat Commun. 2019 May 21;10(1):2261. doi: 10.1038/s41467-019-08620-4. Nat Commun. 2019. PMID: 31113940 Free PMC article.
1,006 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page